[HTML][HTML] Outcomes of kidney transplantation in patients with autosomal dominant polycystic kidney disease: our experience based on 35-years follow-up

TY Tsai, CH Chen, MJ Wu, SF Tsai - Diagnostics, 2022 - mdpi.com
Background and objectives: For patients with end-stage renal disease (ESRD), the best
replacement therapy is renal transplant (RTx) to ensure life with good quality. Autosomal …

Outcomes of Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: Our Experience Based on 35-Years Follow-Up.

TY Tsai, CH Chen, MJ Wu… - Diagnostics (2075-4418), 2022 - search.ebscohost.com
Background and objectives: For patients with end-stage renal disease (ESRD), the best
replacement therapy is renal transplant (RTx) to ensure life with good quality. Autosomal …

Outcomes of Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: Our Experience Based on 35-Years Follow-Up.

TY Tsai, CH Chen, MJ Wu, SF Tsai - Diagnostics (Basel …, 2022 - europepmc.org
Background and objectives: For patients with end-stage renal disease (ESRD), the best
replacement therapy is renal transplant (RTx) to ensure life with good quality. Autosomal …

Outcomes of Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: Our Experience Based on 35-Years Follow-Up

TY Tsai, C Cheng-Hsu, W Ming-Ju… - Diagnostics, 2022 - search.proquest.com
Background and objectives: For patients with end-stage renal disease (ESRD), the best
replacement therapy is renal transplant (RTx) to ensure life with good quality. Autosomal …

[HTML][HTML] Outcomes of Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: Our Experience Based on 35-Years Follow-Up

TY Tsai, CH Chen, MJ Wu, SF Tsai - Diagnostics, 2022 - ncbi.nlm.nih.gov
Background and objectives: For patients with end-stage renal disease (ESRD), the best
replacement therapy is renal transplant (RTx) to ensure life with good quality. Autosomal …

Outcomes of Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: Our Experience Based on 35-Years Follow-Up

TY Tsai, CH Chen, MJ Wu… - Diagnostics (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
Background and objectives: For patients with end-stage renal disease (ESRD), the best
replacement therapy is renal transplant (RTx) to ensure life with good quality. Autosomal …